Search results
Results from the WOW.Com Content Network
The Canadian Centre on Substance Abuse Act (French: Loi sur le Centre canadien de lutte contre les toxicomanies) is Government of Canada legislation signed into law on September 13, 1988. The purpose of the Act is to establish the Canadian Centre on Substance Abuse (now the Canadian Centre on Substance Abuse and Addictions), recognized as a ...
After the publication of the NIH-run antidepressant clinical trial, clinics began opening in which the intravenous ketamine is given for depression. [5] [6] This practice is an off label use of IV ketamine in the United States, though the intranasal version of esketamine has been approved by the FDA for treatment of depression [5] [7] In 2015 there were about 60 such clinics in the US; the ...
The Canadian Red Cross pleaded guilty to criminal charges related to distributing tainted blood products and infecting Canadians with HIV and hepatitis C. [9] [10] [11] As of 2003, the Royal Canadian Mounted Police blood task force had an ongoing investigation into the Arkansas blood sells. [12]
Unlike drug treatment facilities, sobering centers are not intended to provide long-term substance use treatment. Rather sobering centers operate as an alternative to the jail or emergency department in the intoxication phase, with a stay less than a few hours as compared to the more traditional 14-90 day drug treatment programs. However ...
The Canadian Network for Mood and Anxiety Treatments (CANMAT) recommends esketamine as a third-line treatment for depression. [ 26 ] A Cochrane review of randomized controlled trials in adults with unipolar major depressive disorder , [ 19 ] found that when compared with placebo, people treated with either ketamine or esketamine experienced ...
The American Society of Addiction Medicine surveyed each state’s Medicaid program to determine which medications are covered and if any limitations exist. It found that many states’ Medicaid programs either won’t pay for drugs like methadone, place dosage limits on a patient’s prescription for buprenorphine or require counseling that ...
An article published by the Canadian Medical Association Journal discusses new efforts to create safe injection sites for people struggling with opioid addiction. Vancouver politicians created these sites for people to safely use drugs that they are addicted to without the risk of infection or prosecution by the police.
Robert O. Pihl (born February 2, 1939) is an American psychology researcher, professor and clinician. Since 1966, he has worked at McGill University in Montreal, Canada.He is also a fellow of the American Psychological Association and Canadian Psychological Association, [1] as well as a member of many other academic organizations.